OVID THERAPEUTICS INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

Item 2.02. Results of Operations and Financial Condition.

On August 16, 2021, Ovid Therapeutics Inc. (the "Company") issued a press release announcing second quarter 2021 financial results and provides a corporate update. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information provided in this Item 2.02, including Exhibit 99.1 hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01.Financial Statements and Exhibits.

(d) Exhibit



              Exhibit No.   Description

              99.1            Press Release, dated August 16, 2021

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses